Pretreatment levels of serum lactate dehydrogenase (LDH) and clinical outcome in metastatic colorectal cancer patients receiving first-line chemotherapy and bevacizumab.

被引：0
|
作者：
Maccaroni, Elena
Giampieri, Riccardo
Scartozzi, Mario
Del Prete, Michela
Faloppi, Luca
Bianconi, Maristella
Bittoni, Alessandro
Galizia, Eva
Loretelli, Cristian
Belvederesi, Laura
Cascinu, Stefano
机构：
[1] Univ Politecn Marche, Scuola Specializzaz Oncol Med, Ancona, Italy
[2] AO Osped Riuniti Univ Politecn Marche, Ancona, Italy
[3] AO Osped Riuniti Univ Politecn Marche, Clin Oncol Med, Ancona, Italy
[4] Univ Politecn Marche, Scuola Specializzaz Oncol, Ancona, Italy
[5] Osped Profili, Oncol Med, Fabriano, Italy
[6] AO Osped Riuniti Univ Politecn Marche, Ctr Reg Genet Oncol, Ancona, Italy
[7] Univ Politecn Marche, Ctr Reg Genet Oncol, Ancona, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 04期
关键词：
D O I：
10.1200/jco.2012.30.4_suppl.514
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
514
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Visceral fat and clinical outcome in patients receiving first-line chemotherapy with bevacizumab for metastatic colorectal cancer
    Cazeneuve, Nicolas
    Bouche, Olivier
    Leger, Julie
    Borg, Christophe
    Labbe-Devilliers, Catherine
    Lucidarme, Olivier
    Tasu, Jean-Pierre
    Manfredi, Sylvain
    Aube, Christophe
    Trillaud, Herve
    Manzoni, Philippe
    Marcus, Claude
    Terrebonne, Eric
    Douillard, Jean -Yves
    Chautard, Romain
    Lobet, Sarah
    Bleuzen, Aurore
    Lecomte, Thierry
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2024, 48 (07)
  • [2] Addition of Bevacizumab to First-Line Chemotherapy for Metastatic Colorectal Cancer
    Tsutsumi, Soichi
    Fujii, Takaaki
    Yamaguchi, Satoru
    Suto, Toshinaga
    Yajima, Reina
    Morita, Hiroki
    Kato, Toshihide
    Asao, Takayuki
    Kuwano, Hiroyuki
    HEPATO-GASTROENTEROLOGY, 2014, 61 (131) : 633 - 637
  • [3] Bevacizumab in combination with chemotherapy: First-line treatment of patients with metastatic colorectal cancer
    Hochster, Howard S.
    SEMINARS IN ONCOLOGY, 2006, 33 (05) : S8 - S14
  • [4] Clinical value of circulating endothelial cell levels in metastatic colorectal cancer patients treated with first-line chemotherapy and bevacizumab
    Malka, D.
    Boige, V.
    Jacques, N.
    Vimond, N.
    Adenis, A.
    Boucher, E.
    Pierga, J. Y.
    Conroy, T.
    Chauffert, B.
    Francois, E.
    Guichard, P.
    Galais, M. P.
    Cvitkovic, F.
    Ducreux, M.
    Farace, F.
    ANNALS OF ONCOLOGY, 2012, 23 (04) : 919 - U5
  • [5] Pre-treatment lactate dehydrogenase levels as predictor of efficacy of first-line bevacizumab-based therapy in metastatic colorectal cancer patients
    M Scartozzi
    R Giampieri
    E Maccaroni
    M Del Prete
    L Faloppi
    M Bianconi
    E Galizia
    C Loretelli
    L Belvederesi
    A Bittoni
    S Cascinu
    British Journal of Cancer, 2012, 106 : 799 - 804
  • [6] Pre-treatment lactate dehydrogenase levels as predictor of efficacy of first-line bevacizumab-based therapy in metastatic colorectal cancer patients
    Scartozzi, M.
    Giampieri, R.
    Maccaroni, E.
    Del Prete, M.
    Faloppi, L.
    Bianconi, M.
    Galizia, E.
    Loretelli, C.
    Belvederesi, L.
    Bittoni, A.
    Cascinu, S.
    BRITISH JOURNAL OF CANCER, 2012, 106 (05) : 799 - 804
  • [7] BEVACIZUMAB IN COMBINATION WITH CHEMOTHERAPY FOR THE FIRST-LINE TREATMENT OF METASTATIC COLORECTAL CANCER
    Ubago, R.
    Castillo, M. A.
    Flores, S.
    Beltran, C.
    VALUE IN HEALTH, 2011, 14 (07) : A435 - A435
  • [8] Effect of bevacizumab combined with first-line chemotherapy on metastatic colorectal cancer
    Xiong, Lifeng
    Lou, Yinmei
    Wang, Lin
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 13 (04): : 3609 - 3617
  • [9] Clinical outcomes of Chinese patients with metastatic colorectal cancer receiving first-line bevacizumab-containing treatment
    Bai, Long
    Zhang, Dong-sheng
    Wu, Wen-jing
    Ren, Chao
    Wang, De-shen
    Wang, Feng
    Qiu, Miao-zhen
    Xu, Rui-hua
    MEDICAL ONCOLOGY, 2015, 32 (02)
  • [10] Clinical outcomes of Chinese patients with metastatic colorectal cancer receiving first-line bevacizumab-containing treatment
    Long Bai
    Dong-sheng Zhang
    Wen-jing Wu
    Chao Ren
    De-shen Wang
    Feng Wang
    Miao-zhen Qiu
    Rui-hua Xu
    Medical Oncology, 2015, 32
12345